OMER
Omeros Corporation
NASDAQ · Healthcare · Biotechnology · US
$18.95
−0.84%Leverage
- Debt / equity
- -1.63x
- Net debt / equity
- -1.59x
- Debt / assets
- 0.29x
- Debt / EBITDA
- 0.62x
- Net debt / EBITDA
- 0.60x
Liquidity & coverage
- Current ratio
- 1.95x
- Quick ratio
- 1.94x
- Cash ratio
- 1.39x
- Interest coverage
- -3.28x
- EBITDA / interest
- 6.13x
- Working capital
- $90.3M
Cash & dividend
- FCF / debt
- -0.82x
- Cash flow / debt
- -0.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026